medline.ch Onkologie Urologische Tumoren

	The Role of Artificial Intelligence in the Characterization and Outcome Prediction of Prostate Cancer: A Systematic Review. Tomography Aljoudi S, Khan A, Dajani I, Al-Ani M, Mina M, Baroudi D, Al-Saffar S, Aouadi S, Torfeh T, Hammoud R, Al Hammadi N, Yousef MS. PMID: 42188703 [PubMed - indexed for MEDLINE]
	MRI-Derived Biomarkers and Radiomic Signatures for Early, Dose-Dependent Evaluation of Prostate Cancer Radiotherapy: An Exploratory Study. J Imaging Bekou E, Mulita A, Koukourakis IM, Courcoutsakis N, Kotini A, Psatha E, Tsakaldimis G, Seimenis I, Koukourakis MI, Karavasilis E. PMID: 42188250 [PubMed]
	Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications. Curr Oncol Narvel H, Ganiyani MA, Gulam Nabi A, Goyal A, Garje R, Srinivasan S, Ahmed H, Kilari D. PMID: 42187597 [PubMed - indexed for MEDLINE]
	Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis. Curr Oncol Khosh Kish E, Dvorani E, Saskin R, Wilton AS, Satkunasivam R, Aminoltejari K, Hird A, Berscheid K, Roy S, Morgan SC, Ong M, Jiang DM, Gotto GT, Shayegan B, Kulkarni GS, Breau RH, Lalani AA, Nguyen DD, Wallis CJD. PMID: 42187593 [PubMed - indexed for MEDLINE]
	Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression. Cancer Biol Ther Zhong J, Deng Y, Qin X, Yang Q. PMID: 42187002 [PubMed - indexed for MEDLINE]
	Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort study. BMC Urol Mofid B, Jafari A, Simforoosh N, Basiri A, Siavashpour M, Siavashpour Z, Zabihi MS, Ghajari M, Razzaghdoust A. PMID: 42185887 [PubMed - as supplied by publisher]
	Overdiagnosis in renal cancer: the hidden consequence of modern imaging. Int Urol Nephrol Vallecilla Valencia K, Garcia-Perdomo HA. PMID: 42185723 [PubMed - as supplied by publisher]
	ASO Author Reflections: Refining CT Heterogeneity Scoring to Improve Clear Cell Renal Cell Carcinoma Diagnosis in Small Renal Masses. Ann Surg Oncol Zhang W, Li X, Zhu X, Song X, Qu J. PMID: 42185708 [PubMed - as supplied by publisher]
	Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis. J Robot Surg Rabie A, Dovey Z, Falavolti C, Papalia R, Signore S, Martini A, Marco MD, Balah A, Petitti T, Buscarini M, Zaytoun O. PMID: 42185689 [PubMed - indexed for MEDLINE]
	Multi-omics analysis reveals TM4SF19 as a diagnostic and prognostic biomarker in bladder cancer. Discov Oncol Aizezi X, Silafu B, Shi H, Huang J. PMID: 42185687 [PubMed - as supplied by publisher]
	Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study. Sci Rep Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L. PMID: 42185427 [PubMed - as supplied by publisher]
	Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial. Nat Commun Johnson JS, Miller JW, Hatoum F, Schell MJ, Yu X, Roman Souza G, Mizelle S, Gullapalli K, Fazili A, Jain R, Chatzkel J, Cen L, Dhillon J, Cubitt C, Yao J, Whiting J, Li J, Swank J, Jameel G, Zhang J, Wang X, Spiess PE, Fishman M, Chahoud J. PMID: 42185255 [PubMed - as supplied by publisher]
	NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate Cancer. Eur Urol Focus Ravi P, Dorff TB, Morgans AK. PMID: 42185202 [PubMed - as supplied by publisher]
	Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification. Semin Diagn Pathol Nguyen JK. PMID: 42185133 [PubMed - as supplied by publisher]
	Laparoscopic retroperitoneal lymph node dissection in testicular cancer: feasibility and safety at a tertiary center. Cir Cir Scavuzzo A, Calvo-Vázquez I, Reynoso-Noveron N, Pierzo-Lugo C, Barajas-Narvaez E, Jiménez-Ríos MA. PMID: 42184400 [PubMed - indexed for MEDLINE]
	Beyond the stone: nephrolithiasis as a metabolic sentinel in upper tract urothelial carcinoma and papillary renal cell carcinoma: toward a risk-stratified management framework. Int Urol Nephrol Wan S, Gao S, Huang K, Bai Y. PMID: 42184081 [PubMed - as supplied by publisher]
	A nomogram predicting the OS and CSS ofâ€‰â‰¥â€‰T1b renal cell carcinoma patients after surgery. Clin Transl Oncol Zheng J, Wang H, Lv J, Liu C, Lan X, Xu T, Feng M. PMID: 42184075 [PubMed - as supplied by publisher]
	Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring. Ann Surg Oncol Zhang W, Chen Q, Zhu X, Li X, Wang X, Ma H, Song X, Zheng Z, Qu J. PMID: 42183967 [PubMed - as supplied by publisher]
	Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer. Ther Adv Med Oncol Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND. PMID: 42182602 [PubMed]
	Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning. Transl Cancer Res Peng X, Wang Z, Si J, Ji H, Xu G, Chen Y, Du M, Xu M. PMID: 42180890 [PubMed]

Artikel 1 - 20 / 178492

Seite 1 von 8925

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung